Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Clinical Biochemistry,Biochemistry,Analytical Chemistry
Reference23 articles.
1. El-Shaboury SR, Saleh GA, Mohamed FA, Rageh AH (2007) Analysis of Cephalosporin antibiotics. J Pharm Biomed Anal 45:1–19
2. U.S. Food and Drug Administration. Drug Safety and Availability. https://www.fda.gov/drugs/drug-safety-and-availability/drug-recalls. Accessed Dec 2019.
3. International Conference on Harmonisation (2006) Impurities in New Drug Substances Q3A (R2). ICH Harmonised Tripartite Guideline. ICH
4. Hendrix C, Roets E, Bervoets V, Thomas J, Pijcke M, Busson R, Janssen G, Hoogmartens J (1994) Synthesis of potential impurities of cefalexin and cefradine. Arch Pharm 327:215–219
5. Olsen BA, Baertschi SW, Riggin RM (1993) Multidimensional evaluation of impurity profiles for generic cefalexin and cefaclor antibiotics. J Chromatogr 648:165–173
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献